EGFR and cancer: Given its critical role in cancer, several EGFR‐targeted therapies have been developed, including monoclonal humanized antibodies (mAbs) directed against the receptor extracellular domain, as well selective small‐molecule inhibitors targeting the tyrosine kinase domain.